Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.83 |
| ▸ | ITGA4 | P13612 | 20/20 | 0.83 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.52 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6641695 | 0.87 | ITGB1 (0.80) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL6637322 | 0.86 | ITGB1 (0.68) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL6639689 | 0.85 | ITGB1 (0.62) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL6640899 | 0.85 | ITGB1 (0.82) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL6634573 | 0.81 | ITGB1 (0.66) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL15147586 | 0.81 | ITGB1 (0.64) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL15147585 | 0.81 | ITGB1 (0.64) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL6642181 | 0.80 | ITGB1 (0.62) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL7426045 | 0.80 | ITGB1 (0.60) | ITGB1ITGA4ITGA2ITGB7 | |
| SCHEMBL5261252 | 0.80 | CA12 (0.63) | ITGB1ITGA4ITGA2ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1005445-B1 | N-ALKANOYLPHENYLALANINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2004-05-26 | — | — | EP | disclosed |
| EP-1403247-A1 | N-Alkanoylphenylalanine derivatives | F.HOFFMANN-LA ROCHE AG (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6229011-B1 | BINDING INHIBITORS BETWEEN VASCULAR ADHESION MOLECULE-1 AND ALPHA. BETA.INTEGRIN; USEFUL FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES SUCH AS MULTIPLE SCLEROSIS, ASTHMA, AND INFLAMMATORY BOWEL DISEASE | HOFFMAN-LA ROCHE INC. | 2001-05-08 | — | — | US | disclosed |